Morgan Stanley’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.9M Buy
2,434,379
+486,006
+25% +$7.67M ﹤0.01% 2864
2025
Q4
$35.5M Buy
1,948,373
+490,179
+34% +$8.26M ﹤0.01% 2410
2025
Q3
$21.4M Sell
1,458,194
-503,391
-26% -$8.63M ﹤0.01% 2825
2025
Q2
$35.7M Sell
1,961,585
-2,952,343
-60% -$60.2M ﹤0.01% 2232
2025
Q1
$97.5M Sell
4,913,928
-620,409
-11% -$10.7M 0.01% 1264
2024
Q4
$94.9M Sell
5,534,337
-3,065,281
-36% -$57.7M 0.01% 1287
2024
Q3
$172M Buy
8,599,618
+4,001,131
+87% +$62.2M 0.01% 908
2024
Q2
$51.4M Buy
4,598,487
+781,763
+20% +$6.56M ﹤0.01% 1727
2024
Q1
$25.2M Sell
3,816,724
-3,751,642
-50% -$20.5M ﹤0.01% 2444
2023
Q4
$34.2M Buy
7,568,366
+2,328,995
+44% +$8.62M ﹤0.01% 2839
2023
Q3
$18.8M Buy
5,239,371
+1,470,953
+39% +$5.66M ﹤0.01% 2522
2023
Q2
$13.9M Sell
3,768,418
-697,684
-16% -$2.59M ﹤0.01% 2853
2023
Q1
$14.8M Buy
4,466,102
+1,237,766
+38% +$4.28M ﹤0.01% 2751
2022
Q4
$12.5M Buy
3,228,336
+870,715
+37% +$2.69M ﹤0.01% 2846
2022
Q3
$5.73M Buy
2,357,621
+1,498,858
+175% +$3.6M ﹤0.01% 3561
2022
Q2
$1.7M Buy
858,763
+727,377
+554% +$1.43M ﹤0.01% 4651
2022
Q1
$240K Sell
131,386
-178,643
-58% -$279K ﹤0.01% 5816
2021
Q4
$436K Sell
310,029
-328,505
-51% -$432K ﹤0.01% 5625
2021
Q3
$721K Buy
638,534
+217,928
+52% +$305K ﹤0.01% 5277
2021
Q2
$674K Buy
420,606
+40,030
+11% +$70.4K ﹤0.01% 5331
2021
Q1
$670K Buy
380,576
+174,852
+85% +$400K ﹤0.01% 4985
2020
Q4
$401K Sell
205,724
-43,488
-17% -$91.4K ﹤0.01% 5223
2020
Q3
$596K Buy
249,212
+44,683
+22% +$123K ﹤0.01% 4554
2020
Q2
$599K Buy
204,529
+141,196
+223% +$406K ﹤0.01% 4508
2020
Q1
$183K Sell
63,333
-43,973
-41% -$152K ﹤0.01% 4900
2019
Q4
$430K Buy
107,306
+50,254
+88% +$219K ﹤0.01% 5012
2019
Q3
$254K Buy
57,052
+21,770
+62% +$91K ﹤0.01% 5008
2019
Q2
$137K Sell
35,282
-3,732
-10% -$16.5K ﹤0.01% 5180
2019
Q1
$148K Sell
39,014
-25,538
-40% -$90.3K ﹤0.01% 5212
2018
Q4
$154K Sell
64,552
-2,765
-4% -$13.7K ﹤0.01% 5387
2018
Q3
$418K Buy
67,317
+19,137
+40% +$110K ﹤0.01% 5099
2018
Q2
$217K Buy
48,180
+35,169
+270% +$175K ﹤0.01% 5501
2018
Q1
$59K Buy
13,011
+9,237
+245% +$36.7K ﹤0.01% 5845
2017
Q4
$12K Sell
3,774
-1,089
-22% -$3.05K ﹤0.01% 6183
2017
Q3
$15K Sell
4,863
-3,374
-41% -$11.2K ﹤0.01% 6090
2017
Q2
$31K Hold
8,237
﹤0.01% 5984
2017
Q1
$40K Hold
8,237
﹤0.01% 5894
2016
Q4
$42K Sell
8,237
-300
-4% -$1.72K ﹤0.01% 5795
2016
Q3
$62K Sell
8,537
-615
-7% -$3.9K ﹤0.01% 5501
2016
Q2
$55K Sell
9,152
-289
-3% -$2.02K ﹤0.01% 5496
2016
Q1
$76K Buy
9,441
+2,989
+46% +$17.1K ﹤0.01% 5437
2015
Q4
$52K Buy
6,452
+300
+5% +$2.7K ﹤0.01% 5696
2015
Q3
$52K Buy
6,152
+1,524
+33% +$14.1K ﹤0.01% 5712
2015
Q2
$43K Buy
4,628
+3,463
+297% +$29.9K ﹤0.01% 5907
2015
Q1
$11K Buy
1,165
+499
+75% +$5.03K ﹤0.01% 6201
2014
Q4
$7K Buy
+666
New +$7.62K ﹤0.01% 6265

Other funds holding ADMA